Genome-Wide Association Analysis of Body Mass in Chronic Obstructive Pulmonary Disease
Emily S. Wan(Minneapolis VA Medical Center), Dawn L. DeMeo(Brigham and Women's Hospital), Elizabeth A. Regan(National Jewish Health), Michael H. Cho(Brigham and Women's Hospital), Xiangyang Kong(GlaxoSmithKline (United Kingdom)), Wayne H. Anderson(University of North Carolina at Chapel Hill), Edwin K. Silverman(Brigham and Women's Hospital), Nadia Boutaoui(Children's Hospital of Pittsburgh), James D. Crapo(National Jewish Health), Barry J. Make(National Jewish Health), Per Bakke(University of Bergen), Christoph Lange(German Center for Infection Research), Amund Gulsvik(University of Bergen), Barbara J. Klanderman(Harvard University), Sungho Won(Seoul National University), Sreekumar Pillai(GlaxoSmithKline (United States)), Emiel F. Wouters(Maastricht University), James R. Murphy(University of Liverpool), Jody Sylvia, John Ziniti(Brigham and Women's Hospital), David A. Lomas(Institute of Structural and Molecular Biology), Bartolomé R. Celli(Brigham and Women's Hospital)
Cited by 68
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Key Concepts and Advances in Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2013|3.8k
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
|New England Journal of Medicine|2010|3k
International variation in the prevalence of COPD (The BOLD Study): a population-based prevalence study
|The Lancet|2007|2.4k
American Thoracic Society/European Respiratory Society Statement on Pulmonary Rehabilitation
|American Journal of Respiratory and Critical Care Medicine|2006|2k